COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Maternal Variables Associated With Adherence in Children With Asthma (asthma)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00688792
Recruitment Status : Unknown
Verified May 2008 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : June 3, 2008
Last Update Posted : June 3, 2008
Information provided by:
Hadassah Medical Organization

Brief Summary:
A questionnaire will be used in order to find out the reasons for poor adherence for long-term treatment in children with asthma. The hypotheses is maternal factors including the knowledge that asthma is a chronic disease and fear to administer inhaled steroids are major obstacles for appropriate adherence.

Condition or disease

Detailed Description:
Parents to children aged 2 - 12 years with moderate to severe asthma who need long-term treatment with inhaled steroids will be included in the study. Three weeks after their visit in the clinic, they will be requested to answer a questionnaire by telephone.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Reasons for Poor Adherence for Long-Term Preventing Therapy in Children With Asthma
Study Start Date : July 2008
Estimated Primary Completion Date : June 2010
Estimated Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Parents to children aged 2 - 12 years with moderate to severe asthma.

Inclusion Criteria:

  • Parents to children aged 2 - 12 years with moderate to severe asthma to whom inhaled steroids was described for a period of at least 4 weeks.

Exclusion Criteria:

  • Parents who will not agree to sign the consent form and parents who do not speak and understand the Hebrew language.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00688792

Layout table for location contacts
Contact: Dan Engelhard, MD 972-2-677-8960

Layout table for location information
Hadassah Medical Organization
Jerusalem, Israel, 91120
Contact: Arik Tzukert, DMD    972-2-677-6095   
Contact: Hadas Lemberg, PhD    972-2-677-7572   
Principal Investigator: Dan Engelhard, MD         
Sponsors and Collaborators
Hadassah Medical Organization
Layout table for investigator information
Principal Investigator: Dan Engelhard, MD Hadassah Medical Organization

Layout table for additonal information
Responsible Party: Prof. Dan Engelhard, MD, Hadassah Medical Organization Identifier: NCT00688792    
Other Study ID Numbers: asthma1-HMO-CTIL
First Posted: June 3, 2008    Key Record Dates
Last Update Posted: June 3, 2008
Last Verified: May 2008
Keywords provided by Hadassah Medical Organization:
Maternal factors
Additional relevant MeSH terms:
Layout table for MeSH terms
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases